Endocrine and metabolic disorders

Comprehensive formulation and clinical expertise to accelerate therapies for obesity, diabetes, and autoimmune conditions.
Join us for our next webinar
 

Formulation design expertise

using data, scientific rigor, and operational agility to help you overcome molecule complexity. 

Join us for our next webinar
 

Clinical testing strategies

that are aligned with your therapeutic goals, ensuring robust data and regulatory compliance.

Join us for our next webinar
 

Flexible GMP drug product manufacturing

with rapid scale-up and batch release for clinical trials, through to registration batches and sustained commercial supply. 

Recent Partnership
Quotient Sciences is collaborating with Biorasi for expanded access to patient populations for initial proof-of-concept.

Why choose Quotient Sciences?

From the next generation of emerging biotechs, to Fortune 100 pharmaceutical companies, we have worked with countless companies across the pharmaceutical industry over the last 30 years. 

Multiyear Winner of CRO Leadership Awards

Most recently in 2024, for our excellence in conducting Phase I clinical studies for small molecule and synthetic peptide drug programs. 

Winner of 2023 CDMO Leadership Awards

Recognizing top performing outsourcing organizations in the drug development space.

Winner of 2024 Fierce CRO Awards

Recognized for "Innovative Solutions in Drug Development" for the Translational Pharmaceutics platform for drug development.

Your Next Program
Every day counts for patients. Let's move your therapy forward together.